Start here if you're new
what it is
CNA sells business insurance, life coverage, and annuities through agents, brokers, and direct sales.
how it gets paid
Last year Cna Financial made $15.0B in consolidated revenue. Standard Lines was the main engine at $4.50B, or 30% of sales.
why growth slowed
Revenue fell 2.0% last year. On a positive note, net investment income in the fourth quarter of 2025 checked in at $653 million, fueled by a $26 million increase from.
what just happened
CNA posted $1.16 in quarterly EPS, beating the $1.14 estimate by 1.75%, even as underwriting got a little worse.
At a glance
A balance sheet — strong enough to weather a downturn
70/100 earnings predictability — reasonably predictable
9.9x trailing p/e — the market's not buying it — or you found a deal
4.0% dividend yield — cash in your pocket every quarter
7.1% return on capital — nothing to write home about
xvary composite: 71/100 — average
What they do
CNA sells business insurance, life coverage, and annuities through agents, brokers, and direct sales.
Insurance is a trust business. If your broker already places coverage with CNA, switching carriers means rechecking price, claims service, and capital strength all over again. That stickiness is backed by an A balance sheet grade, $3.0B of long-term debt at just 18% of capital, and a 95 price stability score.
How they make money
$15.0B
annual consolidated revenue · their business grew -2.0% last year
Standard Lines
$4.50B
Specialty Lines
$3.75B
CNA Re
$2.25B
Group Operations
$2.25B
Life
$2.25B
The products that matter
commercial property insurance
Property insurance
$15.0B company revenue
This is one of CNA's core lines, but segment revenue is not broken out in this snapshot. What you do know is enough to frame the stock: the whole company generated about $15.0B in consolidated revenue, and the headline revenue change we show is still about -2.0% from last year.
core line
liability and accident coverage
Casualty coverage
A balance sheet
Insurance looks sleepy right up until claims spike. The A balance sheet and $3.0B of long-term debt equal to 18% of capital matter more here than any product brochure, because reserve mistakes show up in the numbers fast.
claims risk
life and group protection
Life & group insurance
4.0% dividend yield
This adds diversification, but your stock case still comes back to earnings power: $5.00 in estimated EPS and a 9.9x trailing P/E. In human-speak: you are being paid to own a stable insurer, not a fast grower.
income support
Key numbers
9.9x
trailing p/e
You are paying 9.9 times earnings for a business with a 4.0% yield, which is cheap if profits hold near $5.00 a share.
4.0%
dividend yield
That yield pays you while you wait, and it beats the payout profile of many large financial stocks.
93.8%
combined ratio
Combined ratio → claims plus expenses over premiums → so what: below 100% means underwriting is still profitable.
$3.0B
long-term debt
Debt is only 18% of capital, which helps explain the A balance sheet grade and gives CNA room to absorb shocks.
Financial health
A
strength
- balance sheet grade A — very strong financial position
- risk rank 2 — safer than 80% of stocks
- price stability 95 / 100
- long-term debt $3.0B (18% of capital)
- return on equity 12% — $0.12 profit for every $1 investors have put in
A — among the top-rated companies for balance sheet quality.
Total return vs. market
You invested $10,000 in CNA 3 years ago → it's now worth $13,630.
The index would have given you $13,880.
source: institutional data · total return
What just happened
beat estimates
CNA posted $1.16 in quarterly EPS, beating the $1.14 estimate by 1.75%, even as underwriting got a little worse.
Latest-quarter revenue was $1.2B, up 202% vs. prior year, and EPS was $3.58, up 142% vs. prior year in EDGAR data. But the December-quarter combined ratio rose to 93.8%, and net premiums earned slipped slightly despite rate increases.
$1.2B
revenue
$1.16
eps
93.8%
combined ratio
the number that mattered
93.8% matters most. Combined ratio → claims and expenses over premiums → so what: it tells you underwriting is still profitable, but less profitable than last year.
-
cna’s earnings fell moderately vs. prior year during the december quarter, though the insurer posted a bottom-line improvement for the full year.
-
looking at the december period in more detail, operating earnings (which exclude capital gains and losses from the investment portfolio) came in at $1.16 a share, which fell short of the previous year’s tally of $1.25.on a positive note, net investment income in the fourth quarter of 2025 checked in at $653 million, fueled by a $26 million increase from fixed-income securities, which more than offset a $17 million decrease from limited partnerships and common stock.
-
on the other hand, the combined ratio increased by 70 basis points (lower is better) from last year, to 93.8%.it should be noted that this figure still implies underwriting profitability, as the company generated $6.20 in pretax income for every $100 in policies insured.
-
finally, net premiums earned fell slightly from a year ago, despite rate increases and an overall upturn in the p/c insurance industry.
-
we believe that this likely reflects management being more selective in its underwriting.
source: company earnings report, 2026
Get this snapshot in your inbox
This page, delivered free — plus weekly updates when the numbers change. plain english, no spam.
weekly updates
earnings alerts
plain english
no spam
What could go wrong
CNA does not need a dramatic failure to disappoint you. This case breaks if underwriting gets sloppy, revenue shrinkage stops looking temporary, or the income story stops covering for weak returns.
med
claims outrun premiums
Insurance math looks easy until claims arrive above what management priced for. With return on capital at 7.1%, CNA does not have a giant profitability cushion.
Insurance math looks easy until claims arrive above what management priced for. With return on capital at 7.1%, CNA does not have a giant profitability cushion.
med
slow growth turns into a longer slide
Revenue already slipped 2.0% from last year. If that keeps happening, 9.9x earnings starts to look less like cheap quality and more like the market reading the room.
Revenue already slipped 2.0% from last year. If that keeps happening, 9.9x earnings starts to look less like cheap quality and more like the market reading the room.
med
the dividend has company
A 4.0% yield is attractive, but CNA also carries $3.0B in long-term debt, equal to 18% of capital. If earnings soften, cash has more than one destination.
A 4.0% yield is attractive, but CNA also carries $3.0B in long-term debt, equal to 18% of capital. If earnings soften, cash has more than one destination.
med
the stock leaves less room for error
At $48.69, shares are much closer to the $51 high than the $43 low. You do not need a broken business for a stable stock to sag if investors decide they want a better entry point.
At $48.69, shares are much closer to the $51 high than the $43 low. You do not need a broken business for a stable stock to sag if investors decide they want a better entry point.
If the combined ratio keeps rising and revenue stays around -2.0% Vs. last year, the cheap valuation stops looking cheap.
source: institutional data · regulatory filings · risk analysis
Pay attention to
valuation
whether the $5.00 EPS estimate holds
At $48.69, the stock trades at about 9.7x that estimate. If earnings hold, the valuation looks reasonable. If they slip, the cheap multiple disappears fast.
ownership
institutional buying staying positive
CNA has seen net buying for three straight quarters, with 162 buyers versus 117 sellers in 3Q2025. If that flips, one quiet source of support goes with it.
targets
how much upside analysts are really offering
The 3–5 year target midpoint is $56, only 15% above today's price. The range runs from $70 to $95, which tells you this is scenario framing, not precision.
kill criteria
what would make the steady case weaker
If revenue keeps shrinking and return on capital stays around 7.1%, this remains a bond proxy with equity risk. That is fine at the right price. It is not a reason to pay up.
Analyst rankings
earnings predictability
70 / 100
in human-speak, the street sees a fairly steady insurer, but not one with perfectly clean quarter-to-quarter numbers.
risk rank
2
This sits in the safer bucket of stocks. Translation: the balance sheet does a lot of the investment-case heavy lifting.
price stability
95 / 100
You are not here for violent upside. You are here because the stock usually behaves itself.
source: institutional data
Institutional activity
institutions have been net buying for 3 consecutive quarters — 162 buyers vs. 117 sellers in 3q2025. total institutional holdings: 0.3B shares. net buying for 3 quarters.
source: institutional data
Price targets
3-5 year target range
$42
$69
$49
current price
$56
target midpoint · +15% from current · 3-5yr high: $95 (+95% · 20% ann'l return)
Want the deeper analysis?
The full deep dive: dcf model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.
see plans from $5/moThe deep dive